Skip to main content

Published locations for EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan

User login

  • Reset your password
  • /content/emperor-reduced-empagliflozins-hfref-benefit-holds-steady-top-sacubitril/valsartan
  • /emed-journal/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds-steady
  • /familypracticenews/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /internalmedicinenews/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /hospitalist/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds-steady
  • /clinicalendocrinologynews/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit
  • /ecardiologynews/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /cardiology/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds-steady
  • /endocrinology/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds-steady
  • /internalmedicine/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /familymedicine/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /emergencymedicine/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit-holds
  • /type-2-diabetes-icymi/article/229543/heart-failure/emperor-reduced-empagliflozins-hfref-benefit